
Jacky Yuen
Examiner (ID: 1754, Phone: (571)270-5749 , Office: P/1735 )
| Most Active Art Unit | 1735 |
| Art Unit(s) | 1735, 1793 |
| Total Applications | 685 |
| Issued Applications | 222 |
| Pending Applications | 70 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17533925
[patent_doc_number] => 20220112534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Compositions and Methods Related to Nucleic Acid Synthesis
[patent_app_type] => utility
[patent_app_number] => 17/554012
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554012 | Compositions and methods related to nucleic acid synthesis | Dec 16, 2021 | Issued |
Array
(
[id] => 17520726
[patent_doc_number] => 20220106575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => KETOREDUCTASE POLYPEPTIDES FOR THE SYNTHESIS OF CHIRAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/553455
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/553455 | Ketoreductase polypeptides for the synthesis of chiral compounds | Dec 15, 2021 | Issued |
Array
(
[id] => 19034457
[patent_doc_number] => 20240084272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/266787
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266787 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | Dec 9, 2021 | Pending |
Array
(
[id] => 17627642
[patent_doc_number] => 20220162657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => GLUCOAMYLASES AND METHODS OF USE, THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/544668
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17544668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/544668 | GLUCOAMYLASES AND METHODS OF USE, THEREOF | Dec 6, 2021 | Abandoned |
Array
(
[id] => 18923328
[patent_doc_number] => 20240026332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => LIQUID ENZYME PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/255349
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255349 | LIQUID ENZYME PREPARATION | Dec 1, 2021 | Pending |
Array
(
[id] => 18879449
[patent_doc_number] => 20240002818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => MAMMALIAN MOBILE ELEMENT COMPOSITIONS, SYSTEMS AND THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/037937
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037937
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037937 | MAMMALIAN MOBILE ELEMENT COMPOSITIONS, SYSTEMS AND THERAPEUTIC APPLICATIONS | Nov 23, 2021 | Pending |
Array
(
[id] => 17444109
[patent_doc_number] => 20220064614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Polypeptide Variants
[patent_app_type] => utility
[patent_app_number] => 17/531220
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531220 | DNase variants | Nov 18, 2021 | Issued |
Array
(
[id] => 19051194
[patent_doc_number] => 20240093163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => aroG Aldolase Variant and Method for Producing Branched Chain Amino Acids by Using Same
[patent_app_type] => utility
[patent_app_number] => 18/274196
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274196
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274196 | aroG Aldolase Variant and Method for Producing Branched Chain Amino Acids by Using Same | Nov 17, 2021 | Pending |
Array
(
[id] => 17761801
[patent_doc_number] => 20220235413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => RECOMBINANT POLYMERASES FOR INCORPORATION OF PROTEIN SHIELD NUCLEOTIDE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/523670
[patent_app_country] => US
[patent_app_date] => 2021-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17523670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/523670 | Recombinant polymerases for incorporation of protein shield nucleotide analogs | Nov 9, 2021 | Issued |
Array
(
[id] => 18923377
[patent_doc_number] => 20240026381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => SPLIT PRIME EDITING PLATFORMS
[patent_app_type] => utility
[patent_app_number] => 18/251505
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -79
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251505 | SPLIT PRIME EDITING PLATFORMS | Nov 2, 2021 | Pending |
Array
(
[id] => 17533916
[patent_doc_number] => 20220112525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => BIOSYNTHESIS OF VANILLIN FROM ISOEUGENOL
[patent_app_type] => utility
[patent_app_number] => 17/514043
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17514043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/514043 | BIOSYNTHESIS OF VANILLIN FROM ISOEUGENOL | Oct 28, 2021 | Abandoned |
Array
(
[id] => 18844947
[patent_doc_number] => 20230407351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => RECOMBINANT HOST CELLS TO PRODUCE ANTHRANILIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/250989
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250989 | RECOMBINANT HOST CELLS TO PRODUCE ANTHRANILIC ACID | Oct 27, 2021 | Pending |
Array
(
[id] => 17579101
[patent_doc_number] => 20220135956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => MODIFIED ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/500831
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500831 | Modified enzymes | Oct 12, 2021 | Issued |
Array
(
[id] => 18771146
[patent_doc_number] => 20230365957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => VACUUM DRYING METHOD FOR BOTULINUM TOXIN
[patent_app_type] => utility
[patent_app_number] => 18/029787
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029787
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029787 | Vacuum drying method for botulinum toxin | Oct 6, 2021 | Issued |
Array
(
[id] => 17735070
[patent_doc_number] => 20220220529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHOD OF SCREENING INHIBITOR OF CASPASE ACTIVITY BY LIPOPOLYSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 17/485606
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485606 | Method of screening inhibitor of caspase activity by lipopolysaccharide | Sep 26, 2021 | Issued |
Array
(
[id] => 17343959
[patent_doc_number] => 20220010290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => MODIFIED POLYMERASES FOR IMPROVED INCORPORATION OF NUCLEOTIDE ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 17/485004
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485004 | MODIFIED POLYMERASES FOR IMPROVED INCORPORATION OF NUCLEOTIDE ANALOGUES | Sep 23, 2021 | Abandoned |
Array
(
[id] => 18726173
[patent_doc_number] => 20230340431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => INACTIVE TELOMERASE, ADENOVIRUS ASSOCIATED VIRUS AND ARTIFICIAL MRNA HAVING SAME AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/027838
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027838
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027838 | INACTIVE TELOMERASE, ADENOVIRUS ASSOCIATED VIRUS AND ARTIFICIAL MRNA HAVING SAME AND USE THEREOF | Sep 21, 2021 | Pending |
Array
(
[id] => 17520727
[patent_doc_number] => 20220106576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => Taq DNA Polymerase Mutants for Probe qPCR
[patent_app_type] => utility
[patent_app_number] => 17/470557
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470557 | Taq DNA polymerase mutants for probe qPCR | Sep 8, 2021 | Issued |
Array
(
[id] => 18675613
[patent_doc_number] => 20230313231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => RNA AND DNA BASE EDITING VIA ENGINEERED ADAR
[patent_app_type] => utility
[patent_app_number] => 18/025169
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025169
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025169 | RNA AND DNA BASE EDITING VIA ENGINEERED ADAR | Sep 7, 2021 | Pending |
Array
(
[id] => 18923387
[patent_doc_number] => 20240026391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => METHODS AND CELLS FOR PRODUCTION OF VOLATILE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/043177
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043177
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043177 | METHODS AND CELLS FOR PRODUCTION OF VOLATILE COMPOUNDS | Aug 31, 2021 | Pending |